- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$24.05 MnMarket Estimate, 2026
$25.85 MnMarket Forecast, 2034
$46.10 MnCAGR, 2026–2034
7.50%Executive Summary: Middle East & Africa Gamma Knife Market
- Market Scope: Regional and country-level analysis of the Middle East & Africa gamma knife sector, detailing disease indications, technological advancements, surgical center adoptions, and market profiles for the forecast period 2026-2034.
- Market Valuation: Valued at USD 25.85 million in 2026 and projected to reach USD 46.10 million by 2034, growing at a robust CAGR of 7.5% from 2026 to 2034.
- Primary Growth Drivers: Increasing prevalence of cancer, brain tumors, and neurological diseases, growing preference for non-invasive surgeries, and continuous technological upgrades in imaging and integrated software.
Key Market Segment Metrics
| Category | Largest Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Disease Indication | Brain Metastasis (dominated market share, driven by high clinical demand for micro-precision non-invasive radiation treatments) | Trigeminal Neuralgia & AVM (expected to register highest growth, fueled by rising neurological disorder diagnoses and stereotactic radiosurgery adoption) |
| By Country | Saudi Arabia & UAE (market leaders holding largest revenue share, backed by well-developed healthcare infrastructure and advanced surgical adoption) | South Africa (key high-growth regional hub driven by rapidly developing healthcare facilities and a growing geriatric population) |
Major Market Players & Industry Landscape
Market Structure: Specialized and consolidated medical device ecosystem characterized by leading global radiation oncology and surgical technology providers partnering with regional hospitals and clinics from 2026 to 2034.
Key Companies: Varian Medical Systems, Elekta AB, Cyber Medical Corporation Ltd., Huiheng Medical Inc., Masep Infini Middle East and Africa, Inc., Hokai, Nordion Inc., ET Medical Group, American Shared Hospital Services, and Others.
Download Free Sample Report
Middle East & Africa Gamma Knife Market Size
The Middle East and Africa gamma knife market size was valued at USD 24.05 million in 2025 and is anticipated to reach USD 25.85 million in 2026 from USD 46.10 million by 2034, growing at a CAGR of 7.5% during the forecast period from 2026 to 2034.
Essential factors such as the increasing prevalence of cancer, brain tumors, and neurological diseases, growing adoption of gamma knife instruments in surgical centers, preference for minimally invasive surgeries, and upgrading and advancements in technology are expected to boost the MEA gamma knife market.
According to 2018 data, the global cancer burden has increased to 18.11 million new cases and 9.65 million cancer-related deaths. This increase in cancer incidence is mainly due to lifestyle changes coupled with the rise in the geriatric population affected by cancer; this drives the need for non-invasive and precise treatment with fewer side effects.
A non-invasive procedure such as the gamma knife has more excellent safety, causes minor damage to surrounding tissues, and offers micro-precision in treating target brain cells. This technology involved in surgery and the attractive advantages over open surgeries is another important growth driver. The rising adoption of gamma knives in surgery centers due to increasing preference for minimally invasive techniques is also expected to drive the market.
The continuous evolution of technology is one of the critical factors attributed to its high adoption. In addition, the adoption of imaging and integrated software, improved workflow, and increased clinical applications have also led to extensive use of these devices in surgical centers.
However, some factors which will affect the MEA gamma knife market involve the high cost of installing the technology and the procedure, which cannot be affordable for everyone. The cost of treatment also depends on the severity of the tumor and its risks. Lack of knowledge about this alternative surgical treatment in emerging countries may also restrain the growth of the studied market.
Geographically, the Middle East & Africa Gamma Knife Market led the overall market in revenue due to the high incidence of brain tumors and the increased awareness among healthcare professionals of non-invasive treatment alternatives during the forecast period.
The UAE Gamma Knife Market is predicted to grow at a decent CAGR due to the high adoption of the latest instruments in surgical centers. In addition, a well-developed healthcare infrastructure will be responsible for the predominance of the region.
The Saudi Arabia Gamma knife Market is considered the second-largest market in sales revenue. The main factors responsible for market growth are the increasing burden of neurological disease, cancers, and brain tumors coupled with the growing adoption of gamma knife instruments in hospitals and clinics.
The South African Gamma Knife Market is projected to witness a decent CAGR due to the rapidly developing economies, improving healthcare facilities, increasing adoption of expensive and technologically advanced products, and increasing geriatric population are some of the factors supporting the growth of the MEA region.
KEY MARKET PLAYERS
Leading companies dominating the MEA Gamma Knife Market profiled in the report are Varian Medical Systems, Elekta AB, Cyber Medical Corporation Ltd., Huiheng Medical Inc., Masep Infini Middle East and Africa, Inc., Hokai, Nordion Inc., ET Medical group, and American Shared Hospital Services among others.
MARKET SEGMENTATION
This research report on the MEA Gamma Knife Market has been segmented and sub-segmented into the following categories.
By Disease Indication
- Brain Metastasis
- Cancer
- Trigeminal Neuralgia
- AVM
- Others
By Country
- KSA
- UAE
- Israel
- rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of MEA